Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06376526
Title IMMUNOPLANT for Newly Diagnosed Multiple Myeloma (IMMUNOPLANT)
Acronym IMMUNOPLANT
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dickran Kazandjian, MD
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.